Template:36540764: Difference between revisions
Ossip Groth (talk | contribs) mNo edit summary |
Ossip Groth (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
*''Monoclonal immunoglobulin diseases include light-chain deposition disease, light- and heavy-chain deposition disease,heavy-chain deposition disease, type I cryoglobulinemia, immune tubular glomerulopathy and fibrillar glomerulopathy. | *''Monoclonal immunoglobulin diseases include light-chain deposition disease, light- and heavy-chain deposition disease,heavy-chain deposition disease, type I cryoglobulinemia, immune tubular glomerulopathy and fibrillar glomerulopathy. In recent years, the spectrum of monoclonal gammopathy has gradually expanded to include tissue deposits of monoisotype Ig but lacks evidence for a circulating monoclonal Ig component.'' | ||
In recent years, the spectrum of monoclonal gammopathy has gradually expanded to include tissue deposits of monoisotype Ig but lacks evidence for a circulating monoclonal Ig component.'' | |||
*''fibrillary glomerulopathy, cryoglobulinemia type 1, membranous glomerulonephritis with IgGκ deposition, light-chain amyloidosis, light- and heavy-chain deposition disease, lupus nephritis, atypical anti-GBM nephritis with IgG deposition and idiopathic MPGN.'' | *''fibrillary glomerulopathy, cryoglobulinemia type 1, membranous glomerulonephritis with IgGκ deposition, light-chain amyloidosis, light- and heavy-chain deposition disease, lupus nephritis, atypical anti-GBM nephritis with IgG deposition and idiopathic MPGN.'' | ||
*daratumumab ==anti cd38 | *daratumumab ==anti cd38 | ||
Latest revision as of 16:40, 4 February 2024
- Monoclonal immunoglobulin diseases include light-chain deposition disease, light- and heavy-chain deposition disease,heavy-chain deposition disease, type I cryoglobulinemia, immune tubular glomerulopathy and fibrillar glomerulopathy. In recent years, the spectrum of monoclonal gammopathy has gradually expanded to include tissue deposits of monoisotype Ig but lacks evidence for a circulating monoclonal Ig component.
- fibrillary glomerulopathy, cryoglobulinemia type 1, membranous glomerulonephritis with IgGκ deposition, light-chain amyloidosis, light- and heavy-chain deposition disease, lupus nephritis, atypical anti-GBM nephritis with IgG deposition and idiopathic MPGN.
- daratumumab ==anti cd38
- 0.8% of kidney biopsies
- 20% terminal ki; 90% graft recurrence w early graft loss.
- nephritic/nphrotic init.
- no cryoglobulins (dd: cryo-crystalglobulinemic disease)